A purinergic hypothesis for immunomodulation.
Di Virgilio
F
F
Istituto di Patologia Generale, Universitàa di Ferrara.
Mutini
C
C
Chiozzi
P
P
Falzoni
S
S
Di Susino
M
M
Sanz
J M
JM
Ferrari
D
D
D000255:Adenosine Triphosphate / Q000378:metabolism* / Q000494:pharmacology; D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000818:Animals; D016923:Cell Death; D002459:Cell Fusion; D006801:Humans; D007107:Immune System / Q000276:immunology / Q000378:metabolism*; D007375:Interleukin-1 / Q000378:metabolism; D015640:Ion Channel Gating; D011687:Purines / Q000378:metabolism*; D018048:Receptors, Purinergic P2 / Q000145:classification / Q000276:immunology / Q000378:metabolism*
D000276:Adjuvants, Immunologic; D007375:Interleukin-1; D011687:Purines; D018048:Receptors, Purinergic P2; D000255:Adenosine Triphosphate